Cargando…
Kidney Function in Patients With Neuromuscular Disease: Creatinine Versus Cystatin C
Background: Accurate measurement of kidney function in patients with neuromuscular disorders is challenging. Cystatin C, a marker not influenced by skeletal muscle degradation, might be of clinical value in these patients. Methods: We consecutively enrolled 39 patients with neuromuscular disorders....
Autores principales: | Screever, Elles M., Kootstra-Ros, Jenny E., Doorn, Joyce, Nieuwenhuis, Jellie A., Meulenbelt, Henk E. J., Meijers, Wouter C., de Boer, Rudolf A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498206/ https://www.ncbi.nlm.nih.gov/pubmed/34630276 http://dx.doi.org/10.3389/fneur.2021.688246 |
Ejemplares similares
-
Estimation of kidney function in patients with primary neuromuscular diseases: is serum cystatin C a better marker of kidney function than creatinine?
por: Aldenbratt, Annika, et al.
Publicado: (2021) -
Multifactorial Diseases of the Heart, Kidneys, Lungs, and Liver and Incident Cancer: Epidemiology and Shared Mechanisms
por: Shi, Canxia, et al.
Publicado: (2023) -
Creatinine and cystatin C: Shooting at a flying target
por: Chao, Chia-Ter
Publicado: (2011) -
Risk Factors for Immune Checkpoint Inhibitor–Mediated Cardiovascular Toxicities
por: Yousif, Laura I., et al.
Publicado: (2023) -
Impact of errors of creatinine and cystatin C equations in the selection of living kidney donors
por: González-Rinne, Ana, et al.
Publicado: (2019)